Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 4;40(8):220.
doi: 10.1007/s12032-023-02109-3.

Recent advances in understanding brain cancer metabolomics: a review

Anirban Goutam Mukherjee  1 , Abilash Valsala Gopalakrishnan  2 , Rama Jayaraj  3   4 , Raja Ganesan  5 , Kaviyarasi Renu  6 , Balachandar Vellingiri  7 , Abhijit Dey  8 , Mohamudha Parveen  9
Affiliations
Review

Recent advances in understanding brain cancer metabolomics: a review

Anirban Goutam Mukherjee et al. Med Oncol. .

Abstract

Regardless of the significant progress made in surgical techniques and adjuvant therapies, brain tumors are a major contributor to cancer-related morbidity and mortality in both pediatric and adult populations. Gliomas represent a significant proportion of cerebral neoplasms, exhibiting diverse levels of malignancy. The etiology and mechanisms of resistance of this malignancy are inadequately comprehended, and the optimization of patient diagnosis and prognosis is a challenge due to the diversity of the disease and the restricted availability of therapeutic options. Metabolomics refers to the comprehensive analysis of endogenous and exogenous small molecules, both in a targeted and untargeted manner, that enables the characterization of an individual's phenotype and offers valuable insights into cellular activity, particularly in the context of cancer biology, including brain tumor biology. Metabolomics has garnered attention in current years due to its potential to facilitate comprehension of the dynamic spatiotemporal regulatory network of enzymes and metabolites that enables cancer cells to adapt to their environment and foster the development of tumors. Metabolic changes are widely acknowledged as a significant characteristic for tracking the advancement of diseases, treatment efficacy, and identifying novel molecular targets for successful medical management. Metabolomics has emerged as an exciting area for personalized medicine and drug discovery, utilizing advanced analytical techniques such as nuclear magnetic resonance spectroscopy (MRS) and mass spectrometry (MS) to achieve high-throughput analysis. This review examines and highlights the latest developments in MRS, MS, and other technologies in studying human brain tumor metabolomics.

Keywords: Brain; Cancer; Metabolites; Metabolomics; Tumor.

PubMed Disclaimer

References

    1. Gavrilovic IT, Posner JB. “Brain metastases: epidemiology and pathophysiology,“ (in eng), J Neurooncol, vol. 75, no. 1, pp. 5–14, Oct 2005.
    1. Ferlay J, Parkin DM, Steliarova-Foucher E. “Estimates of cancer incidence and mortality in Europe in 2008,“ (in eng), Eur J Cancer, vol. 46, no. 4, pp. 765 – 81, Mar 2010.
    1. Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. “CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018,“ (in eng), Neuro Oncol, vol. 23, no. 12 Suppl 2, pp. iii1-iii105, Oct 5 2021.
    1. Weller M, et al. Glioma. Nat reviews Disease primers. 2015;1(1):1–18.
    1. Björkblom B et al. “Distinct metabolic hallmarks of WHO classified adult glioma subtypes,“ (in eng), Neuro Oncol, vol. 24, no. 9, pp. 1454–68, Sep 1 2022.

LinkOut - more resources